DOXAL

Main information

  • Trade name:
  • DOXAL 10 mg coated tablet
  • Dosage:
  • 10 mg
  • Pharmaceutical form:
  • coated tablet
  • Prescription type:
  • Prescription only
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • DOXAL 10 mg coated tablet
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Doxepin
  • Product summary:
  • Suitability for use in older adult patients Doxepini hydrochloridum Avoid using in older persons. Anticholinergic. Sedative. Slightly serotonergic. Significant adverse effects include confusion, cognitive disorder, tremor, arrhytmia, tachycardia, orthostatic hypotension and risk for falls. Weakens the efficacy of anti-Alzheimer`s drugs.

Status

  • Source:
  • Fimea
  • Authorization status:
  • Marketing authorization granted
  • Authorization number:
  • 6104
  • Authorization date:
  • 11-07-2008
  • Last update:
  • 26-07-2018